Parkinson's disease (PD) is a progressive neurodegenerative disorder, which is
characterised by degeneration of distinct neuronal populations, including dopaminergic …

Parkinson's disease (PD) is a progressive, neurodegenerative disease that presents with
significant motor symptoms, for which there is no diagnostic chemical test. We have …

Objective The pathogenesis of Parkinson's disease (PD) involves complex interactions
between environmental and genetic factors. Metabolomics can shed light on alterations in …

Parkinson's disease is the second most common neurodegenerative disease. In the vast
majority of cases the origin is not genetic and the cause is not well understood, although …

Parkinson's disease (PD) shows high heterogeneity with regard to the underlying molecular
pathogenesis involving multiple pathways and mechanisms. Diagnosis is still challenging …

Background Parkinson's disease (PD) is a prevalent neurological disease in the elderly with
increasing morbidity and mortality. Despite enormous efforts, rapid and accurate diagnosis …

Objective To investigate the metabolic profile of serum and urine samples from 23 female
patients with Parkinson's disease (PD) and 23 age and sex-matched controls. Methods We …

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease of the
central nervous system (CNS), which affects mostly older adults. In recent years, the …

Parkinson's disease (PD) is a common neurodegenerative disease in the elderly with a
pathogenesis that remains unclear. We aimed to explore its pathogenesis through plasma …

Objective: To determine whether a Parkinson disease (PD)-specific biochemical signature
might be found in the total body metabolic milieu or in the CSF compartment, especially …